輸精管切除術市場 - 全球行業規模、佔有率、趨勢、機會和預測，按類型、按患者、按最終用戶、按地區和競爭進行細分，2020-2030 年預測

2024 年全球輸精管切除術市場價值為 227.5 億美元，預計在預測期內將實現令人印象深刻的成長，到 2030 年的複合年成長率為 7.60%。 全球輸精管切除術市場是指提供輸精管切除術服務和相關產品的行業。輸精管切除術是一種用於永久性男性避孕的外科手術，其中輸精管（輸送睪丸精子的管道）被切斷或密封。

主要市場促進因素

提高對男性避孕和計劃生育的認知

主要市場挑戰

文化污名與誤解

主要市場趨勢

微創技術

目錄

第 1 章：產品概述

第 2 章：研究方法

第 3 章：執行摘要

第 4 章：顧客之聲

第 5 章：全球輸精管切除術市場展望

• 市場規模和預測
  • 按價值
• 市場佔有率和預測
  • 按類型（傳統、微創、無刀）
  • 按患者（動物、人類）
  • 按最終使用者（醫院和診所、門診護理中心、其他）
  • 按地區
  • 按公司分類（2024）
• 產品市場圖
  • 按類型
  • 根據患者
  • 按最終用戶
  • 按地區

第 6 章：北美輸精管切除術市場展望

• 市場規模和預測
• 市場佔有率和預測
• 北美：國家分析
  • 加拿大
  • 墨西哥

第 7 章：歐洲輸精管切除術市場展望

• 市場規模和預測
• 市場佔有率和預測
• 歐洲：國家分析
  • 英國
  • 法國
  • 義大利
  • 西班牙

第 8 章：亞太地區輸精管切除術市場展望

• 市場規模和預測
• 市場佔有率和預測
• 亞太地區：國家分析
  • 日本
  • 印度
  • 澳洲
  • 韓國

第 9 章：南美洲輸精管切除術市場展望

• 市場規模和預測
• 市場佔有率和預測
• 南美洲：國家分析
  • 阿根廷
  • 哥倫比亞

第 10 章：中東和非洲輸精管切除術市場展望

• 市場規模和預測
• 市場佔有率和預測
• MEA：國家分析
  • 沙烏地阿拉伯
  • 阿拉伯聯合大公國
  • 科威特

第 11 章：市場動態

• 驅動程式
• 挑戰

第 12 章：市場趨勢與發展

• 近期發展
• 合併與收購
• 產品發布

第 13 章：波特五力分析

• 產業競爭
• 新進入者的潛力
• 供應商的力量
• 顧客的力量
• 替代產品的威脅

第 14 章：競爭格局

• Pfizer Inc
• Bristol Myers Squibb SA
• Teva Pharmaceuticals USA Inc
• Upsher-Smith Laboratories Inc
• SMITHFIELD BIOSCIENCE
• Opocrin SPA
• Bioiberica SA
• GSK PLC
• Johnson & Johnson Consumer Inc
• Fresenius SE & Co KGaA

第 15 章：策略建議

第16章 關於出版商,免責事項

Global Vasectomy Market was valued at USD 22.75 Billion in 2024 and is anticipated to project impressive growth in the forecast period with a CAGR of 7.60% through 2030. The global vasectomy market refers to the industry involved in the provision of vasectomy services and related products. Vasectomy is a surgical procedure used for permanent male contraception, where the vas deferens, the tubes that carry sperm from the testicles, are cut or sealed.

Key Market Drivers

Rising Awareness About Male Contraception and Family Planning

The increasing awareness of male contraception and family planning is one of the most significant drivers of the global vasectomy market. Globally, 966 million women of reproductive age are utilizing some form of contraception. Among the 1.9 billion women aged 15 to 49, approximately 874 million rely on modern contraceptive methods, while 92 million use traditional methods. These figures highlight the substantial market penetration of modern contraceptive solutions and the continued demand for both contemporary and conventional birth control options. This shift is fueled by government initiatives, changing societal norms, education programs, and advocacy efforts, all of which contribute to a higher adoption rate of vasectomy as a preferred method of permanent birth control. Governments, international organizations (such as WHO and UNFPA), and NGOs actively promote vasectomy as a safe, effective, and low-cost family planning solution. In many countries, free or heavily subsidized vasectomy procedures are offered as part of public healthcare programs, increasing accessibility for lower-income populations. Some governments provide financial incentives or additional healthcare benefits to men opting for vasectomy, driving adoption rates.

Traditionally, contraception has been considered a woman's responsibility. However, modern awareness programs emphasize that men should also take an active role in birth control. As societies progress toward gender equality, more men are willing to undergo vasectomy to share the responsibility of family planning, reducing the burden on women. As more men become proactive in reproductive health decisions, demand for vasectomy procedures rises, particularly in urban and educated populations. More healthcare professionals, urologists, and family planning counselors are recommending vasectomy as a safe and effective alternative to female sterilization. Historically, misconceptions about vasectomy (such as loss of sexual function or masculinity) have deterred men from opting for the procedure. Educational initiatives are correcting these myths, leading to increased confidence in the procedure. A better-informed population results in greater acceptance of vasectomy, increasing patient willingness to undergo the procedure and expanding the market. Companies and local organizations are integrating vasectomy awareness into employee wellness programs and community healthcare initiatives. The expansion of digital health platforms, social media, and online healthcare providers makes educational content about vasectomy more widely available. This drives higher procedural uptake as men gain easier access to reliable information and healthcare services.

Key Market Challenges

Cultural Stigma and Misconceptions

One of the foremost challenges in the global vasectomy market is the persistence of cultural stigma and misconceptions surrounding the procedure. In some societies, vasectomy is still associated with emasculation or concerns about sexual performance. Misunderstandings about the procedure's reversibility or its impact on masculinity deter potential candidates. Addressing these misconceptions through education and awareness campaigns is crucial to overcoming this challenge.

Key Market Trends

Minimally Invasive Techniques

While minimally invasive techniques, such as non-scalpel vasectomy, have already gained traction, ongoing research and innovation are expected to further refine these approaches. Continued improvements in surgical techniques will lead to even shorter recovery times, reduced discomfort, and fewer complications, making vasectomy an even more attractive choice for potential candidates.

Key Market Players

• Pfizer Inc
• Bristol Myers Squibb SA
• Teva Pharmaceuticals USA Inc
• Upsher-Smith Laboratories Inc
• SMITHFIELD BIOSCIENCE
• Opocrin SPA
• Bioiberica SA
• GSK PLC
• Johnson & Johnson Consumer Inc
• Fresenius SE & Co KGaA

Report Scope:

In this report, the Global Vasectomy Market has been segmented into the following categories, in addition to the industry trends which have also been detailed below:

Vasectomy Market, By Type:

• Conventional
• Minimally Invasive
• No-Scalpel

Vasectomy Market, By Patient:

• Animal
• Human

Vasectomy Market, By End-User:

• Hospitals & Clinics
• Ambulatory Care Centers
• Others

Vasectomy Market, By Region:

• North America
  • United States
  • Canada
  • Mexico
• Europe
  • Germany
  • United Kingdom
  • France
  • Italy
  • Spain
• Asia-Pacific
  • China
  • Japan
  • India
  • Australia
  • South Korea
• South America
  • Brazil
  • Argentina
  • Colombia
• Middle East & Africa
  • South Africa
  • Saudi Arabia
  • UAE
  • Kuwait

Competitive Landscape

Company Profiles: Detailed analysis of the major companies present in the Global Vasectomy Market.

Available Customizations:

Global Vasectomy market report with the given market data, TechSci Research offers customizations according to a company's specific needs. The following customization options are available for the report:

Company Information

• Detailed analysis and profiling of additional market players (up to five).

Table of Contents

1. Product Overview

• 1.1. Market Definition
• 1.2. Scope of the Market
  • 1.2.1. Markets Covered
  • 1.2.2. Years Considered for Study
  • 1.2.3. Key Market Segmentations

2. Research Methodology

• 2.1. Objective of the Study
• 2.2. Baseline Methodology
• 2.3. Key Industry Partners
• 2.4. Major Association and Secondary Sources
• 2.5. Forecasting Methodology
• 2.6. Data Triangulation & Validation
• 2.7. Assumptions and Limitations

3. Executive Summary

• 3.1. Overview of the Market
• 3.2. Overview of Key Market Segmentations
• 3.3. Overview of Key Market Players
• 3.4. Overview of Key Regions/Countries
• 3.5. Overview of Market Drivers, Challenges, Trends

4. Voice of Customer

5. Global Vasectomy Market Outlook

• 5.1. Market Size & Forecast
  • 5.1.1. By Value
• 5.2. Market Share & Forecast
  • 5.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
  • 5.2.2. By Patient (Animal, Human)
  • 5.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 5.2.4. By Region
  • 5.2.5. By Company (2024)
• 5.3. Product Market Map
  • 5.3.1. By Type
  • 5.3.2. By Patient
  • 5.3.3. By End-User
  • 5.3.4. By Region

6. North America Vasectomy Market Outlook

• 6.1. Market Size & Forecast
  • 6.1.1. By Value
• 6.2. Market Share & Forecast
  • 6.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
  • 6.2.2. By Patient (Animal, Human)
  • 6.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 6.2.4. By Country
• 6.3. North America: Country Analysis
  • 6.3.1. United States Vasectomy Market Outlook
    • 6.3.1.1. Market Size & Forecast
      • 6.3.1.1.1. By Value
    • 6.3.1.2. Market Share & Forecast
      • 6.3.1.2.1. By Type
      • 6.3.1.2.2. By Patient
      • 6.3.1.2.3. By End-User
  • 6.3.2. Canada Vasectomy Market Outlook
    • 6.3.2.1. Market Size & Forecast
      • 6.3.2.1.1. By Value
    • 6.3.2.2. Market Share & Forecast
      • 6.3.2.2.1. By Type
      • 6.3.2.2.2. By Patient
      • 6.3.2.2.3. By End-User
  • 6.3.3. Mexico Vasectomy Market Outlook
    • 6.3.3.1. Market Size & Forecast
      • 6.3.3.1.1. By Value
    • 6.3.3.2. Market Share & Forecast
      • 6.3.3.2.1. By Type
      • 6.3.3.2.2. By Patient
      • 6.3.3.2.3. By End-User

7. Europe Vasectomy Market Outlook

• 7.1. Market Size & Forecast
  • 7.1.1. By Value
• 7.2. Market Share & Forecast
  • 7.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
  • 7.2.2. By Patient (Animal, Human)
  • 7.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 7.2.4. By Country
• 7.3. Europe: Country Analysis
  • 7.3.1. Germany Vasectomy Market Outlook
    • 7.3.1.1. Market Size & Forecast
      • 7.3.1.1.1. By Value
    • 7.3.1.2. Market Share & Forecast
      • 7.3.1.2.1. By Type
      • 7.3.1.2.2. By Patient
      • 7.3.1.2.3. By End-User
  • 7.3.2. United Kingdom Vasectomy Market Outlook
    • 7.3.2.1. Market Size & Forecast
      • 7.3.2.1.1. By Value
    • 7.3.2.2. Market Share & Forecast
      • 7.3.2.2.1. By Type
      • 7.3.2.2.2. By Patient
      • 7.3.2.2.3. By End-User
  • 7.3.3. France Vasectomy Market Outlook
    • 7.3.3.1. Market Size & Forecast
      • 7.3.3.1.1. By Value
    • 7.3.3.2. Market Share & Forecast
      • 7.3.3.2.1. By Type
      • 7.3.3.2.2. By Patient
      • 7.3.3.2.3. By End-User
  • 7.3.4. Italy Vasectomy Market Outlook
    • 7.3.4.1. Market Size & Forecast
      • 7.3.4.1.1. By Value
    • 7.3.4.2. Market Share & Forecast
      • 7.3.4.2.1. By Type
      • 7.3.4.2.2. By Patient
      • 7.3.4.2.3. By End-User
  • 7.3.5. Spain Vasectomy Market Outlook
    • 7.3.5.1. Market Size & Forecast
      • 7.3.5.1.1. By Value
    • 7.3.5.2. Market Share & Forecast
      • 7.3.5.2.1. By Type
      • 7.3.5.2.2. By Patient
      • 7.3.5.2.3. By End-User

8. Asia-Pacific Vasectomy Market Outlook

• 8.1. Market Size & Forecast
  • 8.1.1. By Value
• 8.2. Market Share & Forecast
  • 8.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
  • 8.2.2. By Patient (Animal, Human)
  • 8.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 8.2.4. By Country
• 8.3. Asia-Pacific: Country Analysis
  • 8.3.1. China Vasectomy Market Outlook
    • 8.3.1.1. Market Size & Forecast
      • 8.3.1.1.1. By Value
    • 8.3.1.2. Market Share & Forecast
      • 8.3.1.2.1. By Type
      • 8.3.1.2.2. By Patient
      • 8.3.1.2.3. By End-User
  • 8.3.2. Japan Vasectomy Market Outlook
    • 8.3.2.1. Market Size & Forecast
      • 8.3.2.1.1. By Value
    • 8.3.2.2. Market Share & Forecast
      • 8.3.2.2.1. By Type
      • 8.3.2.2.2. By Patient
      • 8.3.2.2.3. By End-User
  • 8.3.3. India Vasectomy Market Outlook
    • 8.3.3.1. Market Size & Forecast
      • 8.3.3.1.1. By Value
    • 8.3.3.2. Market Share & Forecast
      • 8.3.3.2.1. By Type
      • 8.3.3.2.2. By Patient
      • 8.3.3.2.3. By End-User
  • 8.3.4. Australia Vasectomy Market Outlook
    • 8.3.4.1. Market Size & Forecast
      • 8.3.4.1.1. By Value
    • 8.3.4.2. Market Share & Forecast
      • 8.3.4.2.1. By Type
      • 8.3.4.2.2. By Patient
      • 8.3.4.2.3. By End-User
  • 8.3.5. South Korea Vasectomy Market Outlook
    • 8.3.5.1. Market Size & Forecast
      • 8.3.5.1.1. By Value
    • 8.3.5.2. Market Share & Forecast
      • 8.3.5.2.1. By Type
      • 8.3.5.2.2. By Patient
      • 8.3.5.2.3. By End-User

9. South America Vasectomy Market Outlook

• 9.1. Market Size & Forecast
  • 9.1.1. By Value
• 9.2. Market Share & Forecast
  • 9.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
  • 9.2.2. By Patient (Animal, Human)
  • 9.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 9.2.4. By Country
• 9.3. South America: Country Analysis
  • 9.3.1. Brazil Vasectomy Market Outlook
    • 9.3.1.1. Market Size & Forecast
      • 9.3.1.1.1. By Value
    • 9.3.1.2. Market Share & Forecast
      • 9.3.1.2.1. By Type
      • 9.3.1.2.2. By Patient
      • 9.3.1.2.3. By End-User
  • 9.3.2. Argentina Vasectomy Market Outlook
    • 9.3.2.1. Market Size & Forecast
      • 9.3.2.1.1. By Value
    • 9.3.2.2. Market Share & Forecast
      • 9.3.2.2.1. By Type
      • 9.3.2.2.2. By Patient
      • 9.3.2.2.3. By End-User
  • 9.3.3. Colombia Vasectomy Market Outlook
    • 9.3.3.1. Market Size & Forecast
      • 9.3.3.1.1. By Value
    • 9.3.3.2. Market Share & Forecast
      • 9.3.3.2.1. By Type
      • 9.3.3.2.2. By Patient
      • 9.3.3.2.3. By End-User

10. Middle East and Africa Vasectomy Market Outlook

• 10.1. Market Size & Forecast
  • 10.1.1. By Value
• 10.2. Market Share & Forecast
  • 10.2.1. By Type (Conventional, Minimally Invasive, No-Scalpel)
  • 10.2.2. By Patient (Animal, Human)
  • 10.2.3. By End-User (Hospitals & Clinics, Ambulatory Care Centers, Others)
  • 10.2.4. By Country
• 10.3. MEA: Country Analysis
  • 10.3.1. South Africa Vasectomy Market Outlook
    • 10.3.1.1. Market Size & Forecast
      • 10.3.1.1.1. By Value
    • 10.3.1.2. Market Share & Forecast
      • 10.3.1.2.1. By Type
      • 10.3.1.2.2. By Patient
      • 10.3.1.2.3. By End-User
  • 10.3.2. Saudi Arabia Vasectomy Market Outlook
    • 10.3.2.1. Market Size & Forecast
      • 10.3.2.1.1. By Value
    • 10.3.2.2. Market Share & Forecast
      • 10.3.2.2.1. By Type
      • 10.3.2.2.2. By Patient
      • 10.3.2.2.3. By End-User
  • 10.3.3. UAE Vasectomy Market Outlook
    • 10.3.3.1. Market Size & Forecast
      • 10.3.3.1.1. By Value
    • 10.3.3.2. Market Share & Forecast
      • 10.3.3.2.1. By Type
      • 10.3.3.2.2. By Patient
      • 10.3.3.2.3. By End-User
  • 10.3.4. Kuwait Vasectomy Market Outlook
    • 10.3.4.1. Market Size & Forecast
      • 10.3.4.1.1. By Value
    • 10.3.4.2. Market Share & Forecast
      • 10.3.4.2.1. By Type
      • 10.3.4.2.2. By Patient
      • 10.3.4.2.3. By End-User

11. Market Dynamics

• 11.1. Drivers
• 11.2. Challenges

12. Market Trends & Developments

• 12.1. Recent Development
• 12.2. Mergers & Acquisitions
• 12.3. Product Launches

13. Porter's Five Forces Analysis

• 13.1. Competition in the Industry
• 13.2. Potential of New Entrants
• 13.3. Power of Suppliers
• 13.4. Power of Customers
• 13.5. Threat of Substitute Products

14. Competitive Landscape

• 14.1. Pfizer Inc
  • 14.1.1. Business Overview
  • 14.1.2. Product & Service Offerings
  • 14.1.3. Recent Developments
  • 14.1.4. Financials (If Listed)
  • 14.1.5. Key Personnel
  • 14.1.6. SWOT Analysis
• 14.2. Bristol Myers Squibb SA
• 14.3. Teva Pharmaceuticals USA Inc
• 14.4. Upsher-Smith Laboratories Inc
• 14.5. SMITHFIELD BIOSCIENCE
• 14.6. Opocrin SPA
• 14.7. Bioiberica SA
• 14.8. GSK PLC
• 14.9. Johnson & Johnson Consumer Inc
• 14.10. Fresenius SE & Co KGaA

15. Strategic Recommendations

16. About Us & Disclaimer